Cargando…
Soluble CD59 Expressed from an Adenovirus In Vivo Is a Potent Inhibitor of Complement Deposition on Murine Liver Vascular Endothelium
Inappropriate activation of complement on the vascular endothelium of specific organs, or systemically, underlies the etiology of a number of diseases. These disorders include atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, atherosclerosis, age-related macular degenerat...
Autores principales: | Gandhi, Jarel, Cashman, Siobhan M., Kumar-Singh, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123367/ https://www.ncbi.nlm.nih.gov/pubmed/21720565 http://dx.doi.org/10.1371/journal.pone.0021621 |
Ejemplares similares
-
A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration
por: Cashman, Siobhan M., et al.
Publicado: (2011) -
Adeno-Associated Virus Mediated Delivery of a Non-Membrane Targeted Human Soluble CD59 Attenuates Some Aspects of Diabetic Retinopathy in Mice
por: Adhi, Mehreen, et al.
Publicado: (2013) -
Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients
por: Macor, Paolo, et al.
Publicado: (2021) -
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
por: Lei, Janet, et al.
Publicado: (2018) -
Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis
por: Kinderlerer, Anne R, et al.
Publicado: (2006)